Fujifilm Diosynth Biotechnologies announced the completion of the acquisition of Kalon Biotherapeutics, a company that specializes in advanced biologics development manufacturing. Fujifilm Diosynth ...
FUJIFILM Corporation (President: Shigehiro Nakajima, referred to as FUJIFILM hereafter), announced an agreement to acquire Kalon Biotherapeutics, LLC (College Station, Texas, U.S.A., referred to as ...
CMO Fujifilm Diosynth Biotechnologies (FDBU) inked a deal to acquire Kalon Biotherapeutics, another CMO with experience and expertise in vaccine manufacturing. At the initial closing, scheduled in the ...
FUJIFILM announced an agreement to acquire Kalon Biotherapeutics, a biopharmaceutical contract manufacturing organization specializing in vaccine manufacturing. FUJIFILM Corp. will enter the vaccine ...
Acquisition Enhances Texas’ Growing Reputation as a Global Biotechnology Leader MORRISVILLE, N.C. & COLLEGE STATION, Texas--(BUSINESS WIRE)--FUJIFILM Diosynth Biotechnologies U.S.A. Inc. (FDBU), a ...
Morrisville, North Carolina and College Station, Texas, USA, December 18, 2014 / B3C newswire / - FUJIFILM Diosynth Biotechnologies U.S.A. Inc. (FDBU), a FUJIFILM Corporation subsidiary, today ...
FUJIFILM Diosynth Biotechnologies U.S.A. Inc. (FDBU) has announced the completion of its acquisition of Kalon Biotherapeutics LLC, marking an important new chapter in the emergence of the Texas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results